Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,913 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

NCT02808442

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Hôpital Robert-Debré Paris, France
View Trial Details
Completed

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hôpital Saint-Louis Paris, France
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

NCT03180619

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Coalition of Inclusive Medicine Los Angeles, California, United States
  • Silicon Valley Research Institute, Inc San Jose, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Harborview Medical Center Seattle, Washington, United States
View all 30 locations
View Trial Details
Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

NCT01552369

Conditions
Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytomegalovirus Infection, +11 more
Locations
  • Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • Emory Clinic - Transplant Center Atlanta, Georgia, United States
  • Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States
  • Mount Sinai School of Medicine - Medicine - Infectious Diseases New York, United States
View Trial Details

Related conditions